跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方利血平氢氯噻嗪片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Reserpine and Hydrochlorthiazide Tablets
Approved
化学药品
Compound Reserpine and Hydrochlorthiazide Tablets
广州白云山医药集团股份有限公司白云山制药总厂
🇨🇳 National Medical Products Administration
Approval Date
Mar 11, 2020
Approval ID
7LeaeH2okPI
Company
广州白云山医药集团股份有限公司白云山制药总厂
Type
化学药品
Approval Details
Approval Id
7LeaeH2okPI
Approval Number
国药准字H44024410
Generic Name
复方利血平氢氯噻嗪片
Generic Name En
Compound Reserpine and Hydrochlorthiazide Tablets
Drug Type
化学药品
Dosage Form
片剂(薄膜衣)
Strength
复方
Reg Date
2020-03-11
Company Name
广州白云山医药集团股份有限公司白云山制药总厂
Production Company Name
广州白云山医药集团股份有限公司白云山制药总厂
Production Company Address
广州市白云区同和街云祥路88号
Company Detail Path
/organization/yan-zhou-bai-yun-shan-yi-yao-ji-tuan-gu-fen-you-xian-gong-si-bai-yun-shan-zhi-yao-zong-han
Production Company Detail Path
/organization/yan-zhou-bai-yun-shan-yi-yao-ji-tuan-gu-fen-you-xian-gong-si-bai-yun-shan-zhi-yao-zong-han
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 11, 2020
Approval ID
7LeaeH2okPI
Type
化学药品
Back to NMPA Approvals
